http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : 서달덕(D . D . Su) (검색결과 1 건)
- 무료
- 기관 내 무료
- 유료
-
혈액투석 환자의 투석간 체중증가에 미치는 Angiotensin 전환효소 억제제의 효과
김미경(M . K . Kim),윤태득(T . D . Yoon),서달덕(D . D . Su),이진연(J . Y . Lee),김용근(Y . K . Kim),이형걸(H . G . Lee),김태익(T . Y . Kim),최영선(Y . S . Choi),공진민(J . M . Kong) 대한내과학회 1997 대한내과학회지 Vol.52 No.5
N/A Objective: To determine the efficacy of ACE inhibitor on reducing the interdialytic HW gain of patients on maintenance hemodialysis. Methods: A randomized, double blind, placebo controlled crossover study, consisting of one 4-week baseline period and two 4-week treatment periods, which were interposed by a 2-week washout period, was conducted on 21 non-diabetic ESI4D patients on hemodialysis. During the treatment periods, patients were given either fosinopril 10 mg/day or a placebo. Interdialytic BW gain was recorded during the study period and BUN, plasma Na, osmolarity and the agiotensin II level were measured at the end of the baseline and treatment periods. Results: Eight patients were excluded from the study due to incompliance to medication and 13 patients remained in the study. During the baseline period, no correlation was found between interdialytic weight gain and BUN, Na, osmolarity and angiotens in II. There was no difference in the interdialytic weight. increment between the fosinopril-treated (1.0±0.1kg/day, mean±SE) and placebo-treated period (1.0±0.1), The weight increment in both periods was significantly less than that in the baseline period (1.2±0.2), suggesting a psychological influence of both medications on thirst. However, in 8 patients who gained 1.0 kg/day or more during the baseline period, the interdialytic HW increment in fosinopril-treated period (1.3±0.1) was significantly less than that in the placebo period (1.4±0.1, p<0.05 by paired t test). Of these patients, 6 patients gained less and 2 patients showed no difference in the fosinopril period compared with the placebo period. Conclusion: ACE inhibitor may reduce interdialytic BW gain in hemodialysis patients with moderate to high interdialytic weight increment.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
